Syneos Health

Where, how and why can complex issues like circulating tumor DNA, and by extension, minimal residual disease help us to drive novel trial designs that are more patient friendly and concurrently can expedite the safety and efficacy evaluations of novel therapeutics? In this episode of the Syneos Health Podcast, Chief Scientific Officer Nick K. is joined by oncology experts Wael Harb, MD, MBA and Patrick Kelly to discuss how circulating tumor DNA (ctDNA) is transforming cancer treatment and clinical trial design, and its potential to drive more patient-centric, adaptive clinical trials. Listen to the full episode: https://lnkd.in/eE95dgJP #SyneosHealth

There are currently seven tumor-agnostic FDA approvals for patients with advanced cancers. While the central focus of these approvals has been to provide patients access to novel therapies, these seven approvals fall into two archetypes that provide manufacturers with different values: target-focused and productivity-focused. Download our white paper to learn what companies pursuing a tumor-agnostic development path need to understand regarding the unique challenges and how to decide on the appropriate launch activities/commercial models aligning to these tumor-agnostic development archetypes: https://lnkd.in/esaKZXnq #SyneosHealth

Attending the KoNECT International Conference 2024? Our experts will be on the ground, showcasing our capabilities across the asset development spectrum. Find us on the stage, at Booth #Hanra12 in Special Zone or schedule a meeting to discuss your business challenge: https://lnkd.in/ezGUMFrM #SyneosHealth ft. InPyo Hong, So-Ra Lee, Sunnie(Sunyoung) Han

Cell and gene therapies are revolutionizing medicine, and they hold immense potential to transform health outcomes. Attending AusBiotech 2024? Join our industry expert Abhishek Gupta for his keynote presentation outlining why a holistic approach that considers clinical, operational and commercial capabilities is needed to ensure promising technologies successfully progress through the pipeline. Register here: https://lnkd.in/eBB_WT3 #SyneosHealth

?? Syneos Health stands together to recognize World Mental Health Day. Mental well-being is a vital part of our overall health, and we believe that open conversations and supportive environments are essential for everyone to thrive. Together, we can make a difference! #SyneosHealth #WorldMentalHealthDay

In this week’s edition of the Syneos Health Weekly Sync, our experts uncover key considerations for building a strategic patient support plan to improve the drug development process. Learn more about how we can help you optimize your patient support service offerings. #SyneosHealth

We are excited to announce that Costa Panagos has been appointed Chief Executive Officer of Syneos Health. He succeeds Colin Shannon who has been appointed Executive Chairman. Costa is a widely respected leader with more than 25 years of industry expertise having held numerous sales, operational and executive leadership roles. He has a proven track record of operational excellence, attracting and retaining customers and developing talent. He will build on our momentum, further enhance our innovative clinical and commercial solutions and be relentless in the pursuit of customer success. Read more: https://lnkd.in/eqf89T4P #SyneosHealth

In this Pharmaceutical Commerce Magazine article, our industry expert Dave MacLeod, Managing Director of Consulting, discusses the most important attributes when choosing a specialty pharmacy partner. Dive in: https://lnkd.in/gibzXZ5P #SyneosHealth

Avera Health Research Institute (ARI) is the proud recipient of the 2024 Site Excellence in Patient Inclusion Award! Located in South Dakota, ARI has implemented innovative strategies to increase participation from historically underrepresented groups, particularly rural communities and American Indian/Alaska Native (AI/AN) populations. This prestigious award sponsored by Syneos Health recognizes Avera’s outstanding commitment to promoting diversity and inclusion in clinical research. Read the announcement ? https://lnkd.in/ehA538ab

The Syneos Health Global Vaccines Center of Excellence is a diverse group of vaccine experts committed to working collaboratively with our customers to create customized and innovative solutions designed to overcome the unique challenges vaccine sponsors face. In this video, Jaime E. Hernandez, Executive Medical Director & Therapeutic Area Medical Lead of Infectious Diseases and Vaccines at Syneos Health, dives into the role diverse participant populations play in creating more effective vaccines and how we can better engage underserved communities. Attending World Vaccine Congress Europe? Meet with Jaime and the team at booth #84A or schedule a meeting here: https://lnkd.in/eCnA3PSj #SyneosHealth #WVC